MAP 2023: Abstracts

The abstract submission system is now closed.

View the abstracts in the online programme

Abstract submission deadlines

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters by mid-August 2023.

Information for presenters

Detailed instructions for the preparation of slide (oral) presentations and/or posters will be made available by mid-August 2023 in the section “Information for Presenters”.

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to MAP 2023.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Presentation and publication of accepted abstracts

The MAP 2023 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available onsite for Q&A to represent their work.

All accepted abstracts will be published online only in the MAP 2023 Abstract Book, a supplement to ESMO Open.

Publication schedule for accepted abstracts

Details regarding the publication of accepted abstracts are available here.

Merit Travel Grants

A limited number of Merit Travel Grants to MAP 2023 are available, upon application, to first authors under the age of 40 (forty) who submit abstracts considered deserving of recognition. Selection will be made by the MAP 2023 Scientific Committee on a competitive basis from among the accepted abstracts.